Other Trustworthy AI in clinical oversight BioPharma DiveAI can accelerate clinical work and preserve traceability, but only if users can trust it.OtherRead full story pharminent March 30, 2026 (Last updated: March 30, 2026) BioPharma Dive AI can accelerate clinical work and preserve traceability, but only if users can trust it. OtherRead full story Post navigation Previous: Otsuka grows in neuroplastogens with $1.225bn Transcend buyNext: Amgen’s BiTE for lung cancer backed for EU approval Related Stories Other ‘Seismic shift’ as obesity overtakes cancer for R&D returns pharminent May 5, 2026 Other 223: An Interview With Dr. Antn Blatnik on the Molecular Mechanisms Driving Neuromuscular Disease pharminent May 4, 2026 Other FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech pharminent April 29, 2026
